Molecular Depot
Generated 5/10/2026
Executive Summary
Molecular Depot is a privately held life sciences supplier and contract research organization headquartered in San Diego, California. Founded in 2012, the company offers an extensive catalog of research reagents, including peptides, proteins, antibodies, specialty chemicals, and research kits, catering to academic and industrial clients worldwide. By providing both catalog products and custom CRO services, Molecular Depot positions itself as a one-stop shop for researchers, reducing supply chain complexity. The company’s long operating history and broad product portfolio suggest a stable, albeit niche, presence in the competitive life sciences tools market. While specific financial details remain undisclosed, its consistent operation since 2012 indicates steady demand for its offerings, particularly from cost-sensitive academic labs and small biotechs. The company’s private nature limits visibility into growth trajectory, but its established distribution network and consulting services provide a modest competitive moat.
Upcoming Catalysts (preview)
- Q4 2026New product line expansion in antibodies or kits60% success
- TBDStrategic partnership with a major academic institution40% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)